Zafirlukast Patent Expiration
Zafirlukast is Used for increasing the absorption of the drug substance in the body. It was first introduced by Strides Pharma Global Pte Ltd
Zafirlukast Patents
Given below is the list of patents protecting Zafirlukast, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Accolate | US5612367 | Method of enhancing bioavailability of pharmaceutical agents |
Mar 18, 2014
(Expired) | Strides Pharma |
| Accolate | US5482963 | Pharmaceutical agents useful as leukotriene antagonists |
Jan 09, 2013
(Expired) | Strides Pharma |
Zafirlukast's Family Patents
Explore Our Curated Drug Screens
Zafirlukast Generic API Manufacturers
Several generic applications have been filed for Zafirlukast. The first generic version for Zafirlukast was by Dr Reddys Laboratories Ltd and was approved on Nov 18, 2010. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Nov 27, 2023.
Given below is the list of companies who have filed for Zafirlukast generic, along with the locations of their manufacturing plants worldwide.
1. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 2 different strengths of generic version for Zafirlukast. Given below are the details of the strengths of this generic introduced by Annora Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Sep 10, 2020 |
| 20MG | tablet | Prescription | ORAL | AB | Sep 10, 2020 |
Manufacturing Plant Locations New
Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Zafirlukast. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Nov 27, 2023 |
| 20MG | tablet | Prescription | ORAL | AB | Nov 27, 2023 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
3. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Zafirlukast. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Nov 18, 2010 |
| 20MG | tablet | Prescription | ORAL | AB | Nov 18, 2010 |
4. RISING PHARMS
Rising Pharmaceuticals Inc has filed for 2 different strengths of generic version for Zafirlukast. Given below are the details of the strengths of this generic introduced by Rising Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Aug 25, 2022 |
| 10MG | tablet | Prescription | ORAL | AB | Aug 25, 2022 |